Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 38 results:
Συντάκτης Τίτλος Τύπος [ Έτος![(Desc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-desc.png)
Φίλτρα: Συντάκτης is Iosifidis, Elias [Clear All Filters]
Invasive Aspergillosis in Pediatric Leukemia Patients: Prevention and Treatment..
J Fungi (Basel). 5(1),
(2019). Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit..
Microb Drug Resist. 25(5), 712-716.
(2019). Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit..
Mol Biol Rep. 46(3), 3497-3500.
(2019). Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit..
Acta Paediatr. 108(10), 1923-1924.
(2019). Thiamine Deficiency in a Child with Short Bowel Syndrome and Review..
Pediatr Gastroenterol Hepatol Nutr. 22(5), 493-499.
(2019).
(2019). Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area..
J Glob Antimicrob Resist. 20, 214-218.
(2020). Invasive Mucormycosis in Children With Malignancies.
Journal of Pediatric Hematology/Oncology. Publish Ahead of Print,
(2020). Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology..
J Pediatr Hematol Oncol.
(2020). Management of osteoarticular fungal infections in the setting of immunodeficiency..
Expert Rev Anti Infect Ther. 18(5), 461-474.
(2020). Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial..
PLoS One. 15(3), e0229380.
(2020). Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network..
Arch Dis Child. 105(1), 26-31.
(2020). Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection..
Curr Issues Mol Biol. 44(7), 2811-2824.
(2022).